These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9771932)

  • 1. Identification of dithiolethiones with better chemopreventive properties than oltipraz.
    Maxuitenko YY; Libby AH; Joyner HH; Curphey TJ; MacMillan DL; Kensler TW; Roebuck BD
    Carcinogenesis; 1998 Sep; 19(9):1609-15. PubMed ID: 9771932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against aflatoxin B1-induced hepatic toxicity as short-term screen of cancer chemopreventive dithiolethiones.
    Maxuitenko YY; Curphey TJ; Kensler TW; Roebuck BD
    Fundam Appl Toxicol; 1996 Aug; 32(2):250-9. PubMed ID: 8921328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
    Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR
    Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the post-initiation effects of oltipraz on aflatoxin B1-induced preneoplastic foci in a rat model of hepatic tumorigenesis.
    Maxuitenko YY; MacMillan DL; Kensler TW; Roebuck BD
    Carcinogenesis; 1993 Nov; 14(11):2423-5. PubMed ID: 8242875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
    Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
    Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.
    Kensler TW; Groopman JD; Eaton DL; Curphey TJ; Roebuck BD
    Carcinogenesis; 1992 Jan; 13(1):95-100. PubMed ID: 1346373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
    Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
    Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
    Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
    Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
    Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW
    Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver.
    Kelly VP; Ellis EM; Manson MM; Chanas SA; Moffat GJ; McLeod R; Judah DJ; Neal GE; Hayes JD
    Cancer Res; 2000 Feb; 60(4):957-69. PubMed ID: 10706111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the rat.
    Liu YL; Roebuck BD; Yager JD; Groopman JD; Kensler TW
    Toxicol Appl Pharmacol; 1988 May; 93(3):442-51. PubMed ID: 3130679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz.
    Scholl P; Musser SM; Kensler TW; Groopman JD
    Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins.
    Kensler TW; Curphey TJ; Maxiutenko Y; Roebuck BD
    Drug Metabol Drug Interact; 2000; 17(1-4):3-22. PubMed ID: 11201301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention by inducers of carcinogen detoxication enzymes.
    Kensler TW
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones.
    Kwak MK; Egner PA; Dolan PM; Ramos-Gomez M; Groopman JD; Itoh K; Yamamoto M; Kensler TW
    Mutat Res; 2001 Sep; 480-481():305-15. PubMed ID: 11506823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz.
    Egner PA; Gange SJ; Dolan PM; Groopman JD; Muñoz A; Kensler TW
    Carcinogenesis; 1995 Aug; 16(8):1769-73. PubMed ID: 7634402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones.
    Egner PA; Kensler TW; Prestera T; Talalay P; Libby AH; Joyner HH; Curphey TJ
    Carcinogenesis; 1994 Feb; 15(2):177-81. PubMed ID: 8313505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
    Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW
    Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oltipraz: a laboratory and clinical review.
    Benson AB
    J Cell Biochem Suppl; 1993; 17F():278-91. PubMed ID: 8412206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.
    Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.